Part 2 of this series for Global Biosimilars Week dives into the complexities of payer and pharmacy benefit manager (PBM) ...

Trump said during his campaign that he'd make changes to the Affordable Care Act. His plans could reduce benefits for those on Medicaid and Medicare.

Biosimilars hold the potential to dramatically lower health care costs and improve access to life-changing treatments, but ...

The Walgreens location at 255-A Charlois Blvd. in Winston-Salem is set to close on Nov. 20 with customer prescriptions being ...

“Earlier stage biotechs are highly reliant on access to external ... it comes to the future of prescription drugs under the upcoming Trump administration. Future policies are highly dependent ...

Drug and alcohol policies in workplaces need to be a "living document" in the wake of shifting trends in drug accessibility and case law in ... "A lot of opioids are… legitimately prescribed ...

Everyone in Canada deserves access to the medications they need, regardless of where they live or their ability to pay. No Canadian should have to choose between purchasing the medications that keep ...

Regarding drug prices, Mattie said she's unsure that Trump will take on prescription drug ... of all community members and ...

The Biden administration cut pandemic-era health benefits, and the Harris campaign failed to present any comprehensive health ...

The DEA grants a one-year extension on telehealth prescription of addiction medications, kicking resolution on a fraught issue to the second Trump administration.